Filter Results:
(98)
Show Results For
- All HBS Web
(229)
- Faculty Publications (98)
Show Results For
- All HBS Web
(229)
- Faculty Publications (98)
←
Page 5 of 98
Results
- 2004
- Chapter
Genzyme's Gaucher Initiative: Global Risk and Responsibility
By: Christopher A. Bartlett and Andrew N. McLean
- August 2003 (Revised August 2006)
- Case
New Sector Alliance (A): An Entry into Health Care?
By: Regina E. Herzlinger, Stacy Smollin Schwartz and Jeffrey Cronin
Describes the structure of the U.S. health care system and presents a study of a nonprofit consulting firm that hopes to enter the health care system. Includes descriptions of hospitals, doctors, insurers, medical technology providers, medical devices, pharmaceuticals,... View Details
Keywords: Health; Health Care and Treatment; Health Disorders; Nonprofit Organizations; Health Industry; United States
Herzlinger, Regina E., Stacy Smollin Schwartz, and Jeffrey Cronin. "New Sector Alliance (A): An Entry into Health Care?" Harvard Business School Case 304-004, August 2003. (Revised August 2006.)
- June 2003 (Revised March 2008)
- Case
Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene
By: Regina E. Herzlinger and Marc Aquino
Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Marc Aquino. "Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene." Harvard Business School Case 303-044, June 2003. (Revised March 2008.)
- March 2003
- Article
Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State
By: David M. Cutler and Robert S. Huckman
A puzzling feature of many medical innovations is that they simultaneously appear to reduce unit costs and increase total costs. We consider this phenomenon by examining the diffusion of percutaneous transluminal coronary angioplasty (PTCA)—a treatment for coronary... View Details
Keywords: Innovation and Invention; Cost; Health Care and Treatment; Health Disorders; Performance Improvement; Product; New York (state, US)
Cutler, David M., and Robert S. Huckman. "Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State." Journal of Health Economics 22, no. 2 (March 2003): 187–217.
- 2002
- Chapter
Cross Sector Collaboration: Lessons from the International Trachoma Initiative
By: Diana Barrett, James E. Austin and Sheila McCarthy
Keywords: Health Disorders; Health Care and Treatment; Public Sector; Private Sector; Business and Government Relations; International Relations; Health Industry
Barrett, Diana, James E. Austin, and Sheila McCarthy. "Cross Sector Collaboration: Lessons from the International Trachoma Initiative." In Public-Private Partnerships for Public Health, edited by Michael R. Reich.Harvard Series on Population and International Health. Harvard University Press, 2002.
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
Keywords: Programs; Philanthropy and Charitable Giving; Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Pharmaceutical Industry; Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (A)." Harvard Business School Case 301-088, January 2001.
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
Keywords: Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Africa; Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- November 1994
- Case
Dow Corning and the Breast Implant Controversy (A)
By: Willis M. Emmons III, Monica Brand and Greg Keller
In early 1994, Dow Corning Corp. debates whether to participate in a proposed $4.2 billion product liability settlement. Specifically, the firm must decide whether to contribute $2 billion to end a class action suit filed by women suffering from connective tissue... View Details
Keywords: Safety; Ethics; Health Disorders; Government Legislation; Crime and Corruption; Legal Liability; Risk and Uncertainty; Business Strategy; Communication Strategy; Lawsuits and Litigation; Health Industry; Health Industry
Emmons, Willis M., III, Monica Brand, and Greg Keller. "Dow Corning and the Breast Implant Controversy (A)." Harvard Business School Case 795-047, November 1994.
- December 1993 (Revised November 2009)
- Case
Manville Corporation Fiber Glass Group (A)
By: Lynn S. Paine and Sarah Gant
Manville Corp.'s senior managers must decide how to respond to a new scientific study suggesting that fiberglass, the source of 75% of the company's profits, may be another asbestos and must act under conditions of great uncertainty. In particular, when should a... View Details
Keywords: Communication Strategy; Decision Choices and Conditions; Ethics; Health Disorders; Risk Management; Marketing Communications; Product; Corporate Social Responsibility and Impact; Safety; Consumer Products Industry; Industrial Products Industry
Paine, Lynn S., and Sarah Gant. "Manville Corporation Fiber Glass Group (A)." Harvard Business School Case 394-117, December 1993. (Revised November 2009.)
- September 1993 (Revised November 1993)
- Supplement
Partnership for a Drug-Free America (B)
By: V. Kasturi Rangan, Diana Chapman Walsh, Barbara Moeykens and Rima E. Rudd
Rangan, V. Kasturi, Diana Chapman Walsh, Barbara Moeykens, and Rima E. Rudd. "Partnership for a Drug-Free America (B)." Harvard Business School Supplement 594-029, September 1993. (Revised November 1993.)
- November 1992 (Revised June 1993)
- Case
The Advertising Council Teen Alcoholism Campaign: Research and Strategy
By: V. Kasturi Rangan and Jayne D. Kramer
Rangan, V. Kasturi, and Jayne D. Kramer. "The Advertising Council Teen Alcoholism Campaign: Research and Strategy." Harvard Business School Case 593-060, November 1992. (Revised June 1993.)
- May 1992
- Teaching Note
Jim Sawyer (A), (B), and (C), Teaching Note
Teaching Note for (9-383-029), (9-383-030), and (9-383-031). View Details
- April 1991 (Revised November 1997)
- Case
Levi Strauss & Co. and the AIDS Crisis
Keywords: Health Disorders; Employee Relationship Management; Corporate Social Responsibility and Impact; Apparel and Accessories Industry
Tedlow, Richard S. "Levi Strauss & Co. and the AIDS Crisis." Harvard Business School Case 391-198, April 1991. (Revised November 1997.)
- February 1991 (Revised April 1992)
- Teaching Note
New York Against AIDS (A) & (B) and Ad Council's AIDS Campaign (A) & (B), Teaching Note
Teaching Note for (9-590-036), (9-590-037), (9-590-105), and (9-590-106). View Details
- April 1990 (Revised April 1992)
- Supplement
Ad Council's AIDS Campaign (B): Program Adoption
By: V. Kasturi Rangan and Janet Montgomery
The answer to the (A) case. Explains Ad Council's plan. Outlines alliance with American Advertising Federation to enlist support of local Ad clubs, media presentation, and implementation strategy. View Details
Rangan, V. Kasturi, and Janet Montgomery. "Ad Council's AIDS Campaign (B): Program Adoption." Harvard Business School Supplement 590-106, April 1990. (Revised April 1992.)
- March 1990 (Revised March 1992)
- Supplement
New York Against AIDS (B): Backlash to the Advertising Campaign
By: V. Kasturi Rangan and Sohel Karim
Provides a follow-up to the (A) case. View Details
Rangan, V. Kasturi, and Sohel Karim. "New York Against AIDS (B): Backlash to the Advertising Campaign." Harvard Business School Supplement 590-037, March 1990. (Revised March 1992.)
- January 1990
- Case
No Smoking Story
By: Stephen A. Greyser, Roy V. Eales and Norman Klein
Keywords: Health Disorders
Greyser, Stephen A., Roy V. Eales, and Norman Klein. "No Smoking Story." Harvard Business School Case 590-048, January 1990.
- April 1989 (Revised January 1994)
- Case
Novo Industri
By: Michael E. Porter and Michael J. Enright
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details
Keywords: Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry
Porter, Michael E., and Michael J. Enright. "Novo Industri." Harvard Business School Case 389-148, April 1989. (Revised January 1994.)